QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shimamoto, K. Articles by Shigeri, Y. Search for Related Content PubMed PubMed Citation Articles by Shimamoto, K. Articles by Shigeri, Y.

Characterization of Novel L-threo--Benzyloxyaspartate Derivatives, Potent Blockers of the Glutamate Transporters

Suntory Institute for Bioorganic Research, Osaka,Japan (K.S., K.T., T.N.); Kitasato University School of Fisheries Sciences, Iwate, Japan (R.S.); National Institute of Advanced Industrial Science and Technology, Ikeda, Japan (N.Y., Y.S.); and Department of Neurobiology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania (S.G.A.)

Nontransportable blockers of the glutamate transporters are important tools for investigating mechanisms of synaptic transmission. DL-threo--Benzyloxyaspartate (DL-TBOA) is a potent blocker of all subtypes of the excitatory amino acid transporters (EAATs). We characterized novel L-TBOA analogs possessing a substituent on their respective benzene rings. The analogs significantly inhibited labeled glutamate uptake, the most potent of which was (2S,3S)-3-{3-[4-(trifluoromethyl)benzoylamino]benzyloxy}aspartate (TFB-TBOA). In an uptake assay using cells transiently expressing EAATs, the IC₅₀ values of TFB-TBOA for EAAT1, EAAT2, and EAAT3 were 22, 17, and 300 nM, respectively. TFB-TBOA was significantly more potent at inhibiting EAAT1 and EAAT2 compared with L-TBOA (IC₅₀ values for EAAT1-3 were 33, 6.2, and 15 µM, respectively). Electrophysiological analyses revealed that TBOA analogs block the transport-associated currents in all five EAAT subtypes and also block leak currents in EAAT5. The rank order of the analogs for potencies at inhibiting substrate-induced currents was identical to that observed in the uptake assay. However, the kinetics of TFBTBOA differed from the kinetics of L-TBOA, probably because of the strong binding affinity. Notably, TFB-TBOA did not affect other representative neurotransmitter transporters or receptors, including ionotropic and metabotropic glutamate receptors, indicating that it is highly selective for EAATs. Moreover, intracerebroventricular administration of the TBOA analogs induced severe convulsive behaviors in mice, probably because of the accumulation of glutamate. Taken together, these findings indicate that novel TBOA analogs, especially TFB-TBOA, should serve as useful tools for elucidating the physiological roles of the glutamate transporters.

Address correspondence to: Keiko Shimamoto, Suntory Institute for Bioorganic Research, 1-1-1, Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8503, Japan. E-mail: shimamot{at}sunbor.or.jp OR Yasushi Shigeri, National Institute of Advanced Industrial Science and Technology, 1-8-31, Midorigaoka, Ikeda, 563-8577, Japan. E-mail: yasushi.shigeri{at}aist.go.jp

This article has been cited by other articles:

				K. Shimamoto, Y. Otsubo, Y. Shigeri, Y. Yasuda-Kamatani, M. Satoh, S. Kaneko, and T. Nakagawa Characterization of the Tritium-Labeled Analog of L-threo-beta-Benzyloxyaspartate Binding to Glutamate Transporters Mol. Pharmacol., January 1, 2007; 71(1): 294 - 302. [Abstract] [Full Text] [PDF]

				Y. Takayasu, M. Iino, K. Shimamoto, K. Tanaka, and S. Ozawa Glial glutamate transporters maintain one-to-one relationship at the climbing fiber-Purkinje cell synapse by preventing glutamate spillover. J. Neurosci., June 14, 2006; 26(24): 6563 - 6572. [Abstract] [Full Text] [PDF]

				J. Dunlop, H. B. McIlvain, T. A. Carrick, B. Jow, Q. Lu, D. Kowal, S. Lin, A. Greenfield, C. Grosanu, K. Fan, et al. Characterization of Novel Aryl-Ether, Biaryl, and Fluorene Aspartic Acid and Diaminopropionic Acid Analogs as Potent Inhibitors of the High-Affinity Glutamate Transporter EAAT2 Mol. Pharmacol., October 1, 2005; 68(4): 974 - 982. [Abstract] [Full Text] [PDF]

				R. Renden, H. Taschenberger, N. Puente, D. A. Rusakov, R. Duvoisin, L.-Y. Wang, K. P. Lehre, and H. von Gersdorff Glutamate Transporter Studies Reveal the Pruning of Metabotropic Glutamate Receptors and Absence of AMPA Receptor Desensitization at Mature Calyx of Held Synapses J. Neurosci., September 14, 2005; 25(37): 8482 - 8497. [Abstract] [Full Text] [PDF]